Faculty profile

Francois Gros-Louis

ResearcherUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.

Francois Gros-Louis

Researcher

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Tissue-Engineering 3d Cellular Culture Extracellular Vesicles Microenvironment Neurofibroma Neurofibromatosis Personalized Tissue-Engineered Skins Biomarqueurs

Latest papers

Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1.
Neurology. Genetics · 2026
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants.
Nature communications · 2025
Heterozygous NF1 dermal fibroblasts modulate exosomal content to promote angiogenesis in a tissue-engineered skin model of neurofibromatosis type-1.
Journal of neurochemistry · 2023 · senior author

All 8 publications

Latest funding

Étudier le rôle de la matrice extracellulaire dans la Sclérose Latérale Amyotrophique à l'aide de modèles in vitro 3D personnalisés produits par génie tissulaire
CIHR · 2025 · Nominated PI
$1,017,450
Organogenèse de muqueuse nasale autologue pour la reconstruction endoscopique endonasale en chirurgie de la base du crâne
CIHR · 2023 · Co-investigator
$669,376
Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models
CIHR · 2023 · Nominated PI
$1,113,076

All 10 grants and awards

8 publications.

Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1.

Tanase MG, Djilani L, Lamontagne R, Derbel R, Baril M, Roy V, Blais M, Buteau FA, Khuong HT, Gros-Louis F, Leclerc M, Dupre N

Neurology. Genetics2026

DOI: 10.1212/nxg.0000000000200361 PMID: 41878223

An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants.

Nmezi B, Rodriguez Bey G, Oranburg TD, Dudnyk K, Lardo SM, Herdman N, Jacko A, Rubio S, Loeza-Alcocer E, Kofler J, Kim D, Rankin J, Kivuva E, Gutowski N, Schon K, van den Ameele J, Chinnery PF, Sousa SB, Palavra F, Toro C, Pinto E Vairo F, Saute J, Pan L, Alturkustani M, Hammond R, Gros-Louis F, Gold MS, Park Y, Bernard G, Raininko R, Zhou J, Hainer SJ, Padiath QS

Nature communications2025

DOI: 10.1038/s41467-025-56378-9 PMID: 39910058

Heterozygous NF1 dermal fibroblasts modulate exosomal content to promote angiogenesis in a tissue-engineered skin model of neurofibromatosis type-1.

Roy V, Paquet A, Touzel-Deschênes L, Khuong HT, Dupré N, Gros-Louis F

Journal of neurochemistry2023Senior author

DOI: 10.1111/jnc.15982 PMID: 37837197

Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up.

Bussiere N, Mei J, Levesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, Laforce R, De Serres G, Dupre N, Frasnelli J

Chemical senses2022

DOI: 10.1093/chemse/bjac010 PMID: 35522081

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers.

Bussière N, Mei J, Lévesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, De Serres G, Dupré N, Frasnelli J

Chemical senses2021

DOI: 10.1093/chemse/bjab038 PMID: 34423831

An Optimized Approach to Recover Secreted Proteins from Fibroblast Conditioned-Media for Secretomic Analysis.

Paré B, Deschênes LT, Pouliot R, Dupré N, Gros-Louis F

Frontiers in cellular neuroscience2016Senior author

DOI: 10.3389/fncel.2016.00070 PMID: 27064649

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.

Gros-Louis F, Soucy G, Larivière R, Julien JP

Journal of neurochemistry2010First author

DOI: 10.1111/j.1471-4159.2010.06683.x PMID: 20345765

Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.

Gros-Louis F, Andersen PM, Dupre N, Urushitani M, Dion P, Souchon F, D'Amour M, Camu W, Meininger V, Bouchard JP, Rouleau GA, Julien JP

Proceedings of the National Academy of Sciences of the United States of America2009First author

DOI: 10.1073/pnas.0902174106 PMID: 20007371

Something wrong or missing on this profile? Suggest a correction

Francois Gros-Louis

Research

Latest papers

Latest funding

Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1.

An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants.

Heterozygous NF1 dermal fibroblasts modulate exosomal content to promote angiogenesis in a tissue-engineered skin model of neurofibromatosis type-1.

Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up.

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers.

An Optimized Approach to Recover Secreted Proteins from Fibroblast Conditioned-Media for Secretomic Analysis.

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.

Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.

Étudier le rôle de la matrice extracellulaire dans la Sclérose Latérale Amyotrophique à l'aide de modèles in vitro 3D personnalisés produits par génie tissulaire

Organogenèse de muqueuse nasale autologue pour la reconstruction endoscopique endonasale en chirurgie de la base du crâne

Depicting disease heterogeneity in neurofibromatosis type 1 and the role of dermal fibroblasts in the establishment of microenvironment favouring NF1-associated skin tumor formation using personalized tissue-engineered 3D models

Canada Research Chairs - Tier 1

Depicting disease heterogeneity in neurofibromatosis type 1 and the role of microenvironment in NF1-associated skin tumor formation through personalized tissue-engineered 3D models

Canada Research Chair - Tier 2

Pathogenic Pathways and in-vitro modelization of Intracranial Aneurysms in populations of Inuit and French Canadian descent

Tissue-engineered in-vitro skin model to facilitate the identification of disease biomarkers for Amyotrophic Lateral Sclerosis

Scanning electron microscope with energy dispersive X-ray spectroscopy for studies in regenerative medecine

CRC Tier 1

Frequent collaborators

Jean-Pierre Julien

Roxane Pouliot

Gaston De Serres

Robert Hammond

Robert Laforce